nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—CYP2C9—brain cancer	0.036	1	CrCbGaD
Nabilone—CNR1—BDNF signaling pathway—NTRK3—brain cancer	0.00701	0.0578	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Other—SMO—brain cancer	0.00494	0.0407	CbGpPWpGaD
Nabilone—Dry eye—Temozolomide—brain cancer	0.00483	0.00587	CcSEcCtD
Nabilone—Infection—Lomustine—brain cancer	0.00483	0.00587	CcSEcCtD
Nabilone—Pain—Carboplatin—brain cancer	0.00475	0.00577	CcSEcCtD
Nabilone—Stomatitis—Procarbazine—brain cancer	0.00472	0.00573	CcSEcCtD
Nabilone—Mental disability—Carmustine—brain cancer	0.0047	0.00571	CcSEcCtD
Nabilone—Face oedema—Hydroxyurea—brain cancer	0.00469	0.0057	CcSEcCtD
Nabilone—Anorexia—Lomustine—brain cancer	0.00463	0.00563	CcSEcCtD
Nabilone—Epistaxis—Procarbazine—brain cancer	0.00456	0.00554	CcSEcCtD
Nabilone—Mental disability—Temozolomide—brain cancer	0.00454	0.00551	CcSEcCtD
Nabilone—CNR1—telencephalon—brain cancer	0.00448	0.229	CbGeAlD
Nabilone—Body temperature increased—Carboplatin—brain cancer	0.00439	0.00534	CcSEcCtD
Nabilone—Hallucination—Procarbazine—brain cancer	0.00432	0.00525	CcSEcCtD
Nabilone—Decreased appetite—Lomustine—brain cancer	0.00422	0.00513	CcSEcCtD
Nabilone—Nasal congestion—Temozolomide—brain cancer	0.00417	0.00506	CcSEcCtD
Nabilone—Hot flush—Temozolomide—brain cancer	0.00406	0.00493	CcSEcCtD
Nabilone—Flushing—Procarbazine—brain cancer	0.00403	0.0049	CcSEcCtD
Nabilone—Menopausal symptoms—Temozolomide—brain cancer	0.00402	0.00489	CcSEcCtD
Nabilone—CNR2—head—brain cancer	0.00401	0.205	CbGeAlD
Nabilone—Thirst—Temozolomide—brain cancer	0.00399	0.00485	CcSEcCtD
Nabilone—Chills—Procarbazine—brain cancer	0.0039	0.00474	CcSEcCtD
Nabilone—Arrhythmia—Procarbazine—brain cancer	0.00388	0.00471	CcSEcCtD
Nabilone—Body temperature increased—Lomustine—brain cancer	0.00384	0.00467	CcSEcCtD
Nabilone—Face oedema—Carmustine—brain cancer	0.00379	0.00461	CcSEcCtD
Nabilone—Drowsiness—Hydroxyurea—brain cancer	0.00374	0.00455	CcSEcCtD
Nabilone—Affect lability—Temozolomide—brain cancer	0.00374	0.00454	CcSEcCtD
Nabilone—Tension—Procarbazine—brain cancer	0.00371	0.00451	CcSEcCtD
Nabilone—Ataxia—Carmustine—brain cancer	0.00369	0.00449	CcSEcCtD
Nabilone—Nervousness—Procarbazine—brain cancer	0.00367	0.00446	CcSEcCtD
Nabilone—Face oedema—Temozolomide—brain cancer	0.00366	0.00445	CcSEcCtD
Nabilone—CNR2—central nervous system—brain cancer	0.00366	0.187	CbGeAlD
Nabilone—CNR2—GPCR ligand binding—PTCH2—brain cancer	0.00366	0.0301	CbGpPWpGaD
Nabilone—Stomatitis—Hydroxyurea—brain cancer	0.00365	0.00443	CcSEcCtD
Nabilone—Mood swings—Temozolomide—brain cancer	0.0036	0.00437	CcSEcCtD
Nabilone—Ataxia—Temozolomide—brain cancer	0.00357	0.00434	CcSEcCtD
Nabilone—Tremor—Procarbazine—brain cancer	0.00354	0.0043	CcSEcCtD
Nabilone—Anaemia—Procarbazine—brain cancer	0.00349	0.00425	CcSEcCtD
Nabilone—CNR1—N-cadherin signaling events—CTNNB1—brain cancer	0.00341	0.0281	CbGpPWpGaD
Nabilone—Syncope—Procarbazine—brain cancer	0.00339	0.00412	CcSEcCtD
Nabilone—Leukopenia—Procarbazine—brain cancer	0.00338	0.00411	CcSEcCtD
Nabilone—Hallucination—Hydroxyurea—brain cancer	0.00334	0.00406	CcSEcCtD
Nabilone—Loss of consciousness—Procarbazine—brain cancer	0.00332	0.00404	CcSEcCtD
Nabilone—Cough—Procarbazine—brain cancer	0.0033	0.00401	CcSEcCtD
Nabilone—Convulsion—Procarbazine—brain cancer	0.00328	0.00398	CcSEcCtD
Nabilone—Hypertension—Procarbazine—brain cancer	0.00326	0.00397	CcSEcCtD
Nabilone—Myalgia—Procarbazine—brain cancer	0.00322	0.00391	CcSEcCtD
Nabilone—Arthralgia—Procarbazine—brain cancer	0.00322	0.00391	CcSEcCtD
Nabilone—Anxiety—Procarbazine—brain cancer	0.00321	0.0039	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—OR4C12—brain cancer	0.00321	0.0264	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—OR14C36—brain cancer	0.00321	0.0264	CbGpPWpGaD
Nabilone—Sweating increased—Temozolomide—brain cancer	0.0032	0.00388	CcSEcCtD
Nabilone—Dry mouth—Procarbazine—brain cancer	0.00315	0.00382	CcSEcCtD
Nabilone—Confusional state—Procarbazine—brain cancer	0.00311	0.00378	CcSEcCtD
Nabilone—Vomiting—Lomustine—brain cancer	0.00309	0.00375	CcSEcCtD
Nabilone—Infection—Procarbazine—brain cancer	0.00307	0.00372	CcSEcCtD
Nabilone—Shock—Procarbazine—brain cancer	0.00304	0.00369	CcSEcCtD
Nabilone—Pollakiuria—Temozolomide—brain cancer	0.00303	0.00368	CcSEcCtD
Nabilone—Depression—Carmustine—brain cancer	0.00302	0.00367	CcSEcCtD
Nabilone—Chills—Hydroxyurea—brain cancer	0.00302	0.00366	CcSEcCtD
Nabilone—Tachycardia—Procarbazine—brain cancer	0.00301	0.00366	CcSEcCtD
Nabilone—Photosensitivity reaction—Temozolomide—brain cancer	0.00299	0.00364	CcSEcCtD
Nabilone—Hyperhidrosis—Procarbazine—brain cancer	0.00298	0.00362	CcSEcCtD
Nabilone—Stomatitis—Carmustine—brain cancer	0.00295	0.00358	CcSEcCtD
Nabilone—Anorexia—Procarbazine—brain cancer	0.00294	0.00357	CcSEcCtD
Nabilone—Depression—Temozolomide—brain cancer	0.00292	0.00354	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—OR4C12—brain cancer	0.00291	0.024	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—OR14C36—brain cancer	0.00291	0.024	CbGpPWpGaD
Nabilone—CNR2—brain—brain cancer	0.00291	0.149	CbGeAlD
Nabilone—Nausea—Lomustine—brain cancer	0.00289	0.00351	CcSEcCtD
Nabilone—Hypotension—Procarbazine—brain cancer	0.00288	0.0035	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—PTCH2—brain cancer	0.00287	0.0236	CbGpPWpGaD
Nabilone—Stomatitis—Temozolomide—brain cancer	0.00285	0.00346	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00281	0.00342	CcSEcCtD
Nabilone—Insomnia—Procarbazine—brain cancer	0.00279	0.00339	CcSEcCtD
Nabilone—Paraesthesia—Procarbazine—brain cancer	0.00277	0.00337	CcSEcCtD
Nabilone—Somnolence—Procarbazine—brain cancer	0.00274	0.00333	CcSEcCtD
Nabilone—Ill-defined disorder—Hydroxyurea—brain cancer	0.00271	0.0033	CcSEcCtD
Nabilone—Anaemia—Hydroxyurea—brain cancer	0.0027	0.00329	CcSEcCtD
Nabilone—Hallucination—Carmustine—brain cancer	0.0027	0.00329	CcSEcCtD
Nabilone—Hypoaesthesia—Carmustine—brain cancer	0.0027	0.00329	CcSEcCtD
Nabilone—Decreased appetite—Procarbazine—brain cancer	0.00268	0.00326	CcSEcCtD
Nabilone—Fatigue—Procarbazine—brain cancer	0.00266	0.00323	CcSEcCtD
Nabilone—Malaise—Hydroxyurea—brain cancer	0.00264	0.00321	CcSEcCtD
Nabilone—Pain—Procarbazine—brain cancer	0.00264	0.00321	CcSEcCtD
Nabilone—Constipation—Procarbazine—brain cancer	0.00264	0.00321	CcSEcCtD
Nabilone—Leukopenia—Hydroxyurea—brain cancer	0.00262	0.00318	CcSEcCtD
Nabilone—Visual impairment—Carmustine—brain cancer	0.00262	0.00318	CcSEcCtD
Nabilone—Hallucination—Temozolomide—brain cancer	0.00261	0.00317	CcSEcCtD
Nabilone—Hypoaesthesia—Temozolomide—brain cancer	0.00261	0.00317	CcSEcCtD
Nabilone—Pharyngitis—Temozolomide—brain cancer	0.00261	0.00317	CcSEcCtD
Nabilone—Sweating increased—Etoposide—brain cancer	0.00256	0.00311	CcSEcCtD
Nabilone—Feeling abnormal—Procarbazine—brain cancer	0.00254	0.00309	CcSEcCtD
Nabilone—Eye disorder—Carmustine—brain cancer	0.00254	0.00309	CcSEcCtD
Nabilone—Convulsion—Hydroxyurea—brain cancer	0.00254	0.00308	CcSEcCtD
Nabilone—Visual impairment—Temozolomide—brain cancer	0.00253	0.00307	CcSEcCtD
Nabilone—Gastrointestinal pain—Procarbazine—brain cancer	0.00252	0.00307	CcSEcCtD
Nabilone—Flushing—Carmustine—brain cancer	0.00252	0.00306	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—OR4C12—brain cancer	0.00252	0.0207	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—OR14C36—brain cancer	0.00252	0.0207	CbGpPWpGaD
Nabilone—CNR1—cerebellum—brain cancer	0.00249	0.127	CbGeAlD
Nabilone—Discomfort—Hydroxyurea—brain cancer	0.00246	0.00299	CcSEcCtD
Nabilone—Eye disorder—Temozolomide—brain cancer	0.00245	0.00298	CcSEcCtD
Nabilone—Tinnitus—Temozolomide—brain cancer	0.00245	0.00297	CcSEcCtD
Nabilone—Abdominal pain—Procarbazine—brain cancer	0.00244	0.00296	CcSEcCtD
Nabilone—Body temperature increased—Procarbazine—brain cancer	0.00244	0.00296	CcSEcCtD
Nabilone—Flushing—Temozolomide—brain cancer	0.00244	0.00296	CcSEcCtD
Nabilone—Arrhythmia—Carmustine—brain cancer	0.00243	0.00295	CcSEcCtD
Nabilone—Infection—Hydroxyurea—brain cancer	0.00237	0.00288	CcSEcCtD
Nabilone—Chills—Temozolomide—brain cancer	0.00236	0.00286	CcSEcCtD
Nabilone—Back pain—Carmustine—brain cancer	0.00229	0.00278	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—OR14C36—brain cancer	0.00228	0.0188	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—OR4C12—brain cancer	0.00228	0.0188	CbGpPWpGaD
Nabilone—Stomatitis—Etoposide—brain cancer	0.00228	0.00277	CcSEcCtD
Nabilone—Anorexia—Hydroxyurea—brain cancer	0.00228	0.00277	CcSEcCtD
Nabilone—Hypersensitivity—Procarbazine—brain cancer	0.00227	0.00276	CcSEcCtD
Nabilone—Vision blurred—Carmustine—brain cancer	0.00223	0.00271	CcSEcCtD
Nabilone—Tremor—Carmustine—brain cancer	0.00222	0.00269	CcSEcCtD
Nabilone—Asthenia—Procarbazine—brain cancer	0.00221	0.00269	CcSEcCtD
Nabilone—Back pain—Temozolomide—brain cancer	0.00221	0.00269	CcSEcCtD
Nabilone—Anaemia—Carmustine—brain cancer	0.00219	0.00266	CcSEcCtD
Nabilone—Pruritus—Procarbazine—brain cancer	0.00218	0.00265	CcSEcCtD
Nabilone—Agitation—Carmustine—brain cancer	0.00217	0.00264	CcSEcCtD
Nabilone—Vision blurred—Temozolomide—brain cancer	0.00215	0.00262	CcSEcCtD
Nabilone—Tremor—Temozolomide—brain cancer	0.00214	0.0026	CcSEcCtD
Nabilone—Dyspnoea—Hydroxyurea—brain cancer	0.00213	0.00259	CcSEcCtD
Nabilone—Somnolence—Hydroxyurea—brain cancer	0.00212	0.00258	CcSEcCtD
Nabilone—Ill-defined disorder—Temozolomide—brain cancer	0.00212	0.00258	CcSEcCtD
Nabilone—Leukopenia—Carmustine—brain cancer	0.00212	0.00257	CcSEcCtD
Nabilone—Anaemia—Temozolomide—brain cancer	0.00211	0.00257	CcSEcCtD
Nabilone—Diarrhoea—Procarbazine—brain cancer	0.00211	0.00257	CcSEcCtD
Nabilone—Dyspepsia—Hydroxyurea—brain cancer	0.0021	0.00255	CcSEcCtD
Nabilone—Agitation—Temozolomide—brain cancer	0.0021	0.00255	CcSEcCtD
Nabilone—Hypoaesthesia—Etoposide—brain cancer	0.00209	0.00254	CcSEcCtD
Nabilone—Decreased appetite—Hydroxyurea—brain cancer	0.00208	0.00252	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—SPP1—brain cancer	0.00207	0.0171	CbGpPWpGaD
Nabilone—Malaise—Temozolomide—brain cancer	0.00206	0.0025	CcSEcCtD
Nabilone—Fatigue—Hydroxyurea—brain cancer	0.00206	0.0025	CcSEcCtD
Nabilone—Vertigo—Temozolomide—brain cancer	0.00205	0.0025	CcSEcCtD
Nabilone—Convulsion—Carmustine—brain cancer	0.00205	0.00249	CcSEcCtD
Nabilone—Leukopenia—Temozolomide—brain cancer	0.00205	0.00249	CcSEcCtD
Nabilone—Hypertension—Carmustine—brain cancer	0.00204	0.00248	CcSEcCtD
Nabilone—Pain—Hydroxyurea—brain cancer	0.00204	0.00248	CcSEcCtD
Nabilone—Constipation—Hydroxyurea—brain cancer	0.00204	0.00248	CcSEcCtD
Nabilone—Dizziness—Procarbazine—brain cancer	0.00204	0.00248	CcSEcCtD
Nabilone—CNR1—brain—brain cancer	0.00202	0.103	CbGeAlD
Nabilone—Palpitations—Temozolomide—brain cancer	0.00202	0.00245	CcSEcCtD
Nabilone—Chest pain—Carmustine—brain cancer	0.00201	0.00245	CcSEcCtD
Nabilone—Myalgia—Carmustine—brain cancer	0.00201	0.00245	CcSEcCtD
Nabilone—Anxiety—Carmustine—brain cancer	0.00201	0.00244	CcSEcCtD
Nabilone—Cough—Temozolomide—brain cancer	0.00199	0.00242	CcSEcCtD
Nabilone—Convulsion—Temozolomide—brain cancer	0.00198	0.00241	CcSEcCtD
Nabilone—Hypertension—Temozolomide—brain cancer	0.00197	0.0024	CcSEcCtD
Nabilone—Feeling abnormal—Hydroxyurea—brain cancer	0.00197	0.00239	CcSEcCtD
Nabilone—Eye disorder—Etoposide—brain cancer	0.00196	0.00239	CcSEcCtD
Nabilone—Vomiting—Procarbazine—brain cancer	0.00196	0.00238	CcSEcCtD
Nabilone—Flushing—Etoposide—brain cancer	0.00195	0.00237	CcSEcCtD
Nabilone—Confusional state—Carmustine—brain cancer	0.00195	0.00237	CcSEcCtD
Nabilone—Arthralgia—Temozolomide—brain cancer	0.00195	0.00236	CcSEcCtD
Nabilone—Myalgia—Temozolomide—brain cancer	0.00195	0.00236	CcSEcCtD
Nabilone—Rash—Procarbazine—brain cancer	0.00195	0.00236	CcSEcCtD
Nabilone—Dermatitis—Procarbazine—brain cancer	0.00194	0.00236	CcSEcCtD
Nabilone—Anxiety—Temozolomide—brain cancer	0.00194	0.00236	CcSEcCtD
Nabilone—Headache—Procarbazine—brain cancer	0.00193	0.00235	CcSEcCtD
Nabilone—Discomfort—Temozolomide—brain cancer	0.00192	0.00234	CcSEcCtD
Nabilone—Infection—Carmustine—brain cancer	0.00192	0.00233	CcSEcCtD
Nabilone—Dry mouth—Temozolomide—brain cancer	0.0019	0.00231	CcSEcCtD
Nabilone—Body temperature increased—Hydroxyurea—brain cancer	0.00189	0.00229	CcSEcCtD
Nabilone—Chills—Etoposide—brain cancer	0.00189	0.00229	CcSEcCtD
Nabilone—Tachycardia—Carmustine—brain cancer	0.00188	0.00229	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—SHH—brain cancer	0.00188	0.0155	CbGpPWpGaD
Nabilone—Confusional state—Temozolomide—brain cancer	0.00188	0.00229	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PTCH2—brain cancer	0.00188	0.0155	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—IRS2—brain cancer	0.00188	0.0155	CbGpPWpGaD
Nabilone—Infection—Temozolomide—brain cancer	0.00185	0.00225	CcSEcCtD
Nabilone—Anorexia—Carmustine—brain cancer	0.00184	0.00224	CcSEcCtD
Nabilone—Nausea—Procarbazine—brain cancer	0.00183	0.00223	CcSEcCtD
Nabilone—Hypotension—Carmustine—brain cancer	0.0018	0.00219	CcSEcCtD
Nabilone—Hyperhidrosis—Temozolomide—brain cancer	0.0018	0.00219	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—SMO—brain cancer	0.00179	0.0147	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—PTCH1—brain cancer	0.00179	0.0147	CbGpPWpGaD
Nabilone—Anorexia—Temozolomide—brain cancer	0.00178	0.00216	CcSEcCtD
Nabilone—Back pain—Etoposide—brain cancer	0.00177	0.00215	CcSEcCtD
Nabilone—Hypersensitivity—Hydroxyurea—brain cancer	0.00176	0.00214	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Carmustine—brain cancer	0.00176	0.00214	CcSEcCtD
Nabilone—Insomnia—Carmustine—brain cancer	0.00175	0.00212	CcSEcCtD
Nabilone—Paraesthesia—Carmustine—brain cancer	0.00173	0.00211	CcSEcCtD
Nabilone—Dyspnoea—Carmustine—brain cancer	0.00172	0.00209	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—OR14C36—brain cancer	0.00172	0.0142	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—OR4C12—brain cancer	0.00172	0.0142	CbGpPWpGaD
Nabilone—Somnolence—Carmustine—brain cancer	0.00172	0.00209	CcSEcCtD
Nabilone—Asthenia—Hydroxyurea—brain cancer	0.00171	0.00208	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.0017	0.00207	CcSEcCtD
Nabilone—Ill-defined disorder—Etoposide—brain cancer	0.0017	0.00206	CcSEcCtD
Nabilone—Anaemia—Etoposide—brain cancer	0.00169	0.00205	CcSEcCtD
Nabilone—Insomnia—Temozolomide—brain cancer	0.00169	0.00205	CcSEcCtD
Nabilone—Decreased appetite—Carmustine—brain cancer	0.00168	0.00204	CcSEcCtD
Nabilone—Paraesthesia—Temozolomide—brain cancer	0.00168	0.00204	CcSEcCtD
Nabilone—Dyspnoea—Temozolomide—brain cancer	0.00166	0.00202	CcSEcCtD
Nabilone—Somnolence—Temozolomide—brain cancer	0.00166	0.00202	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—APC—brain cancer	0.00166	0.0136	CbGpPWpGaD
Nabilone—Constipation—Carmustine—brain cancer	0.00165	0.00201	CcSEcCtD
Nabilone—Pain—Carmustine—brain cancer	0.00165	0.00201	CcSEcCtD
Nabilone—Malaise—Etoposide—brain cancer	0.00165	0.002	CcSEcCtD
Nabilone—Vertigo—Etoposide—brain cancer	0.00164	0.002	CcSEcCtD
Nabilone—Dyspepsia—Temozolomide—brain cancer	0.00164	0.002	CcSEcCtD
Nabilone—Leukopenia—Etoposide—brain cancer	0.00164	0.00199	CcSEcCtD
Nabilone—Diarrhoea—Hydroxyurea—brain cancer	0.00163	0.00199	CcSEcCtD
Nabilone—Decreased appetite—Temozolomide—brain cancer	0.00162	0.00197	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—ABR—brain cancer	0.00162	0.0134	CbGpPWpGaD
Nabilone—Fatigue—Temozolomide—brain cancer	0.00161	0.00195	CcSEcCtD
Nabilone—Loss of consciousness—Etoposide—brain cancer	0.00161	0.00195	CcSEcCtD
Nabilone—Cough—Etoposide—brain cancer	0.0016	0.00194	CcSEcCtD
Nabilone—Pain—Temozolomide—brain cancer	0.0016	0.00194	CcSEcCtD
Nabilone—Constipation—Temozolomide—brain cancer	0.0016	0.00194	CcSEcCtD
Nabilone—Feeling abnormal—Carmustine—brain cancer	0.00159	0.00193	CcSEcCtD
Nabilone—Convulsion—Etoposide—brain cancer	0.00158	0.00193	CcSEcCtD
Nabilone—Hypertension—Etoposide—brain cancer	0.00158	0.00192	CcSEcCtD
Nabilone—Dizziness—Hydroxyurea—brain cancer	0.00158	0.00192	CcSEcCtD
Nabilone—Gastrointestinal pain—Carmustine—brain cancer	0.00158	0.00192	CcSEcCtD
Nabilone—Chest pain—Etoposide—brain cancer	0.00156	0.00189	CcSEcCtD
Nabilone—Discomfort—Etoposide—brain cancer	0.00154	0.00187	CcSEcCtD
Nabilone—Feeling abnormal—Temozolomide—brain cancer	0.00154	0.00187	CcSEcCtD
Nabilone—Abdominal pain—Carmustine—brain cancer	0.00153	0.00185	CcSEcCtD
Nabilone—Body temperature increased—Carmustine—brain cancer	0.00153	0.00185	CcSEcCtD
Nabilone—Gastrointestinal pain—Temozolomide—brain cancer	0.00153	0.00185	CcSEcCtD
Nabilone—Vomiting—Hydroxyurea—brain cancer	0.00152	0.00184	CcSEcCtD
Nabilone—Rash—Hydroxyurea—brain cancer	0.00151	0.00183	CcSEcCtD
Nabilone—Confusional state—Etoposide—brain cancer	0.00151	0.00183	CcSEcCtD
Nabilone—Dermatitis—Hydroxyurea—brain cancer	0.0015	0.00183	CcSEcCtD
Nabilone—Headache—Hydroxyurea—brain cancer	0.0015	0.00182	CcSEcCtD
Nabilone—Infection—Etoposide—brain cancer	0.00148	0.0018	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—SHH—brain cancer	0.00148	0.0122	CbGpPWpGaD
Nabilone—Abdominal pain—Temozolomide—brain cancer	0.00147	0.00179	CcSEcCtD
Nabilone—Body temperature increased—Temozolomide—brain cancer	0.00147	0.00179	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—ABR—brain cancer	0.00147	0.0121	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTCH2—brain cancer	0.00147	0.0121	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—DTX2—brain cancer	0.00146	0.012	CbGpPWpGaD
Nabilone—Tachycardia—Etoposide—brain cancer	0.00146	0.00177	CcSEcCtD
Nabilone—Hyperhidrosis—Etoposide—brain cancer	0.00144	0.00175	CcSEcCtD
Nabilone—Anorexia—Etoposide—brain cancer	0.00142	0.00173	CcSEcCtD
Nabilone—Hypersensitivity—Carmustine—brain cancer	0.00142	0.00173	CcSEcCtD
Nabilone—Nausea—Hydroxyurea—brain cancer	0.00142	0.00172	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—PTCH1—brain cancer	0.0014	0.0115	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—SMO—brain cancer	0.0014	0.0115	CbGpPWpGaD
Nabilone—Hypotension—Etoposide—brain cancer	0.00139	0.00169	CcSEcCtD
Nabilone—Asthenia—Carmustine—brain cancer	0.00139	0.00168	CcSEcCtD
Nabilone—Hypersensitivity—Temozolomide—brain cancer	0.00137	0.00167	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—OR14C36—brain cancer	0.00135	0.0111	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—OR4C12—brain cancer	0.00135	0.0111	CbGpPWpGaD
Nabilone—Paraesthesia—Etoposide—brain cancer	0.00134	0.00163	CcSEcCtD
Nabilone—Asthenia—Temozolomide—brain cancer	0.00134	0.00163	CcSEcCtD
Nabilone—Dyspnoea—Etoposide—brain cancer	0.00133	0.00162	CcSEcCtD
Nabilone—Somnolence—Etoposide—brain cancer	0.00133	0.00161	CcSEcCtD
Nabilone—Diarrhoea—Carmustine—brain cancer	0.00132	0.0016	CcSEcCtD
Nabilone—Pruritus—Temozolomide—brain cancer	0.00132	0.0016	CcSEcCtD
Nabilone—Decreased appetite—Etoposide—brain cancer	0.0013	0.00158	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—RELA—brain cancer	0.00129	0.0107	CbGpPWpGaD
Nabilone—Fatigue—Etoposide—brain cancer	0.00129	0.00156	CcSEcCtD
Nabilone—Dizziness—Carmustine—brain cancer	0.00128	0.00155	CcSEcCtD
Nabilone—Pain—Etoposide—brain cancer	0.00128	0.00155	CcSEcCtD
Nabilone—Constipation—Etoposide—brain cancer	0.00128	0.00155	CcSEcCtD
Nabilone—Diarrhoea—Temozolomide—brain cancer	0.00128	0.00155	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—ABR—brain cancer	0.00127	0.0105	CbGpPWpGaD
Nabilone—Dizziness—Temozolomide—brain cancer	0.00123	0.0015	CcSEcCtD
Nabilone—Feeling abnormal—Etoposide—brain cancer	0.00123	0.00149	CcSEcCtD
Nabilone—Vomiting—Carmustine—brain cancer	0.00123	0.00149	CcSEcCtD
Nabilone—Gastrointestinal pain—Etoposide—brain cancer	0.00122	0.00148	CcSEcCtD
Nabilone—Rash—Carmustine—brain cancer	0.00122	0.00148	CcSEcCtD
Nabilone—Dermatitis—Carmustine—brain cancer	0.00122	0.00148	CcSEcCtD
Nabilone—Headache—Carmustine—brain cancer	0.00121	0.00147	CcSEcCtD
Nabilone—Vomiting—Temozolomide—brain cancer	0.00119	0.00144	CcSEcCtD
Nabilone—Abdominal pain—Etoposide—brain cancer	0.00118	0.00143	CcSEcCtD
Nabilone—Body temperature increased—Etoposide—brain cancer	0.00118	0.00143	CcSEcCtD
Nabilone—Rash—Temozolomide—brain cancer	0.00118	0.00143	CcSEcCtD
Nabilone—Dermatitis—Temozolomide—brain cancer	0.00118	0.00143	CcSEcCtD
Nabilone—Headache—Temozolomide—brain cancer	0.00117	0.00142	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—ABR—brain cancer	0.00116	0.00952	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DTX2—brain cancer	0.00115	0.00945	CbGpPWpGaD
Nabilone—Nausea—Carmustine—brain cancer	0.00115	0.00139	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—CTNNB1—brain cancer	0.00113	0.00927	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTCH2—brain cancer	0.00111	0.00913	CbGpPWpGaD
Nabilone—Nausea—Temozolomide—brain cancer	0.00111	0.00135	CcSEcCtD
Nabilone—Hypersensitivity—Etoposide—brain cancer	0.0011	0.00134	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HES5—brain cancer	0.00107	0.00884	CbGpPWpGaD
Nabilone—Asthenia—Etoposide—brain cancer	0.00107	0.0013	CcSEcCtD
Nabilone—Pruritus—Etoposide—brain cancer	0.00106	0.00128	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—STRADA—brain cancer	0.00104	0.00858	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—TRPC6—brain cancer	0.00103	0.00845	CbGpPWpGaD
Nabilone—Diarrhoea—Etoposide—brain cancer	0.00102	0.00124	CcSEcCtD
Nabilone—Dizziness—Etoposide—brain cancer	0.000987	0.0012	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—STAT3—brain cancer	0.000981	0.00808	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—SHH—brain cancer	0.000966	0.00796	CbGpPWpGaD
Nabilone—Vomiting—Etoposide—brain cancer	0.000949	0.00115	CcSEcCtD
Nabilone—Rash—Etoposide—brain cancer	0.000941	0.00114	CcSEcCtD
Nabilone—Dermatitis—Etoposide—brain cancer	0.00094	0.00114	CcSEcCtD
Nabilone—Headache—Etoposide—brain cancer	0.000935	0.00114	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—TRPC6—brain cancer	0.000932	0.00768	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTCH1—brain cancer	0.000916	0.00755	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—SMO—brain cancer	0.000916	0.00755	CbGpPWpGaD
Nabilone—Nausea—Etoposide—brain cancer	0.000887	0.00108	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ABR—brain cancer	0.00087	0.00716	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTCH2—brain cancer	0.00087	0.00716	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HES5—brain cancer	0.000842	0.00694	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GLI2—brain cancer	0.00084	0.00692	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STRADA—brain cancer	0.000818	0.00674	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—TRPC6—brain cancer	0.000805	0.00663	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GLI1—brain cancer	0.00079	0.00651	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—VAV1—brain cancer	0.000769	0.00633	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—SHH—brain cancer	0.000758	0.00625	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SUFU—brain cancer	0.000749	0.00617	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—TRPC6—brain cancer	0.000731	0.00602	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GFAP—brain cancer	0.000722	0.00595	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—SMO—brain cancer	0.000719	0.00592	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTCH1—brain cancer	0.000719	0.00592	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—VAV1—brain cancer	0.000698	0.00575	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HEY1—brain cancer	0.000685	0.00564	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ABR—brain cancer	0.000682	0.00562	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—DLL1—brain cancer	0.000671	0.00553	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GLI2—brain cancer	0.000659	0.00543	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GLI1—brain cancer	0.00062	0.0051	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—VAV1—brain cancer	0.000603	0.00497	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SUFU—brain cancer	0.000587	0.00484	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SHH—brain cancer	0.000571	0.0047	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GFAP—brain cancer	0.000567	0.00467	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TRPC6—brain cancer	0.000551	0.00454	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—VAV1—brain cancer	0.000548	0.00451	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTCH1—brain cancer	0.000541	0.00446	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SMO—brain cancer	0.000541	0.00446	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HEY1—brain cancer	0.000537	0.00443	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DLL1—brain cancer	0.000527	0.00434	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CG—brain cancer	0.000488	0.00402	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SHH—brain cancer	0.000448	0.00369	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CG—brain cancer	0.000443	0.00365	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH2—brain cancer	0.000433	0.00356	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TRPC6—brain cancer	0.000432	0.00356	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTCH1—brain cancer	0.000425	0.0035	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SMO—brain cancer	0.000425	0.0035	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VAV1—brain cancer	0.000412	0.0034	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CG—brain cancer	0.000383	0.00316	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HES1—brain cancer	0.000355	0.00292	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CG—brain cancer	0.000348	0.00287	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—IL2—brain cancer	0.000344	0.00283	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH2—brain cancer	0.00034	0.0028	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFRA—brain cancer	0.000338	0.00278	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SPP1—brain cancer	0.000328	0.0027	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VAV1—brain cancer	0.000324	0.00267	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL2—brain cancer	0.000312	0.00257	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS2—brain cancer	0.000297	0.00244	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HES1—brain cancer	0.000278	0.00229	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2—brain cancer	0.00027	0.00222	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDGFRA—brain cancer	0.000265	0.00218	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APC—brain cancer	0.000262	0.00216	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CG—brain cancer	0.000262	0.00216	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SPP1—brain cancer	0.000257	0.00212	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL2—brain cancer	0.000245	0.00202	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EGFR—brain cancer	0.000239	0.00197	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS2—brain cancer	0.000233	0.00192	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APC—brain cancer	0.000206	0.00169	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CG—brain cancer	0.000206	0.00169	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RELA—brain cancer	0.000205	0.00169	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB2—brain cancer	0.000203	0.00168	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—brain cancer	0.000187	0.00154	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2—brain cancer	0.000184	0.00152	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCND1—brain cancer	0.00018	0.00148	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CTNNB1—brain cancer	0.000178	0.00147	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RELA—brain cancer	0.000161	0.00132	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB2—brain cancer	0.00016	0.00131	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—brain cancer	0.000157	0.00129	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—brain cancer	0.000155	0.00128	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—brain cancer	0.000145	0.00119	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—brain cancer	0.000144	0.00119	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCND1—brain cancer	0.000141	0.00116	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—brain cancer	0.000141	0.00116	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CTNNB1—brain cancer	0.00014	0.00115	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—brain cancer	0.000123	0.00101	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—brain cancer	0.000122	0.001	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—brain cancer	0.000118	0.000975	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—brain cancer	0.000113	0.000932	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—brain cancer	0.000111	0.000911	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—brain cancer	9.29e-05	0.000765	CbGpPWpGaD
